![]() Postmarketing reports: Pathological gamblingĪripiprazole Extended/Prolonged-Release IM Suspension: PsychiatricĪripiprazole (the active ingredient contained in Aristada Initio) lauroxil Extended-Release IM Suspension:Ĭommon (1% to 10%): Insomnia, restlessnessįrequency not reported: Aggression, anorgasmia, anxiety, catatonia, delirium, homicidal ideation, libido increased, loss of libido, other compulsive behaviors, suicide, tic Oral Formulations: The most commonly reported side effects included extrapyramidal disorder, headache, and somnolence. Immediate-Release IM Injection: The most commonly reported side effects included extrapyramidal symptoms, headache, nausea, and dizziness. ![]() GeneralĪripiprazole (the active ingredient contained in Aristada Initio) lauroxil Extended-Release IM Suspension: The most commonly reported side effects included akathisia, headache, injection site reactions, and insomnia.Īripiprazole Extended/Prolonged-Release IM Suspension: The most commonly reported side effects included increased weight, headache, akathisia, and insomnia.
0 Comments
Leave a Reply. |